(GDRX) Goodrx Holdings - Ratings and Ratios

GoodRx Holdings, Inc. (NASDAQ:GDRX) operates a digital health platform that empowers consumers to make informed decisions and save on prescription medications. The company provides real-time, geographically specific pricing data, enabling users to compare costs across pharmacies and access discounted rates. Beyond its core prescription savings tools, GoodRx offers a suite of healthcare solutions, including subscription services, telehealth consultations through GoodRx Care, and pet medication discounts. Additionally, the platform serves as a critical resource for pharmacy benefit managers, facilitating transparent pricing and transaction processes between consumers and pharmacies. Founded in 2011, GoodRx is headquartered in Santa Monica, California, and has established itself as a leader in the health technology sector.

From a technical standpoint, GDRX is currently trading at $4.63, with a 20-day average volume of 845,413 shares. The stock is below its 20-day SMA of $4.46 but slightly above its 50-day SMA of $4.59. The 200-day SMA stands at $5.79, indicating a potential downward trend over the longer term. The Average True Range (ATR) of 0.24 reflects moderate volatility.

Fundamentally, GoodRx has a market capitalization of $1.72 billion, with a trailing P/E ratio of 112.13 and a forward P/E of 10.60, suggesting investor expectations for future earnings growth. The price-to-book ratio is 2.37, and the price-to-sales ratio is 2.17, indicating a premium valuation relative to book value and revenue. Return on equity (RoE) is 3.41%, which is relatively low compared to industry peers.